N. Nagel

776 total citations
51 papers, 621 citations indexed

About

N. Nagel is a scholar working on Organic Chemistry, Physical and Theoretical Chemistry and Inorganic Chemistry. According to data from OpenAlex, N. Nagel has authored 51 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 15 papers in Physical and Theoretical Chemistry and 15 papers in Inorganic Chemistry. Recurrent topics in N. Nagel's work include Crystallography and molecular interactions (14 papers), Crystal structures of chemical compounds (8 papers) and Drug Solubulity and Delivery Systems (6 papers). N. Nagel is often cited by papers focused on Crystallography and molecular interactions (14 papers), Crystal structures of chemical compounds (8 papers) and Drug Solubulity and Delivery Systems (6 papers). N. Nagel collaborates with scholars based in Germany, United Kingdom and France. N. Nagel's co-authors include Hans Bock, Gregor Cevc, Zdeněk Havlas, Christian Näther, Ulrich Vierl, E Jaeger, Harald Berchtold, Stephan König, Walter Göhring and Hans J. Schramm and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Biophysical Journal.

In The Last Decade

N. Nagel

50 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Nagel Germany 13 216 209 108 96 89 51 621
Sherman T. Waddell United States 16 290 1.3× 424 2.0× 112 1.0× 66 0.7× 54 0.6× 30 825
Janak Singh India 18 274 1.3× 433 2.1× 89 0.8× 54 0.6× 57 0.6× 40 763
Elżbieta Bednarek Poland 21 416 1.9× 292 1.4× 132 1.2× 38 0.4× 70 0.8× 91 1.1k
Wojciech Bocian Poland 19 340 1.6× 281 1.3× 95 0.9× 34 0.4× 41 0.5× 72 836
Brigitte E. Segmüller United States 12 114 0.5× 292 1.4× 160 1.5× 71 0.7× 83 0.9× 22 629
Lajos Kovács Hungary 16 275 1.3× 197 0.9× 31 0.3× 41 0.4× 36 0.4× 86 658
Ingeborg I. Schuster United States 17 117 0.5× 339 1.6× 87 0.8× 63 0.7× 106 1.2× 32 659
M. Ramanadham India 15 395 1.8× 94 0.4× 266 2.5× 43 0.4× 159 1.8× 64 884
Diogo Vila‐Viçosa Portugal 21 475 2.2× 233 1.1× 215 2.0× 78 0.8× 127 1.4× 36 994
Raquel Castillo Spain 17 329 1.5× 312 1.5× 121 1.1× 42 0.4× 65 0.7× 49 776

Countries citing papers authored by N. Nagel

Since Specialization
Citations

This map shows the geographic impact of N. Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Nagel more than expected).

Fields of papers citing papers by N. Nagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Nagel. The network helps show where N. Nagel may publish in the future.

Co-authorship network of co-authors of N. Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of N. Nagel. A scholar is included among the top collaborators of N. Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Nagel. N. Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Riddhiman, Krister Bokvist, Manuel Krewinkel, et al.. (2024). Atomic resolution structure of full-length human insulin fibrils. Proceedings of the National Academy of Sciences. 121(23). e2401458121–e2401458121. 12 indexed citations
2.
Gräwert, Tobias, et al.. (2023). Small-angle x-ray scattering investigation of the integration of free fatty acids in polysorbate 20 micelles. Biophysical Journal. 122(15). 3078–3088. 2 indexed citations
3.
Weber, Stefan, et al.. (2023). In-situ investigation of solid phase evolution during lyophilization of mannitol-based antibody formulations using an XRPD climate chamber. European Journal of Pharmaceutical Sciences. 184. 106407–106407. 1 indexed citations
5.
Nagel, N., et al.. (2020). An example of how to establish the thermodynamic stability relationship between two polymorphs of a compound highly prone to solvate formation. European Journal of Pharmaceutical Sciences. 145. 105215–105215. 1 indexed citations
6.
Wolff, Martin, Klaus Gast, Robert Seckler, et al.. (2020). Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains. Molecular Pharmaceutics. 17(3). 965–978. 6 indexed citations
7.
Nagel, N., Melissa A. Graewert, Mimi Gao, et al.. (2019). The quaternary structure of insulin glargine and glulisine under formulation conditions. Biophysical Chemistry. 253. 106226–106226. 15 indexed citations
8.
Gast, Klaus, Martin Wolff, Anja Thalhammer, et al.. (2017). Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation. Pharmaceutical Research. 34(11). 2270–2286. 36 indexed citations
9.
Shen, Jian, N. Nagel, Gregory A. Nemeth, et al.. (2013). Enantiomeric characterization and structure elucidation of Otamixaban. Journal of Pharmaceutical Analysis. 4(3). 197–204. 5 indexed citations
10.
Byard, Stephen J., et al.. (2013). An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137 – A successful approach. European Journal of Pharmaceutics and Biopharmaceutics. 86(3). 337–350. 11 indexed citations
11.
Feth, Martin P., et al.. (2010). Challenges in the development of hydrate phases as active pharmaceutical ingredients – An example. European Journal of Pharmaceutical Sciences. 42(1-2). 116–129. 24 indexed citations
12.
Nagel, N., et al.. (2000). Dimorphism and inclusion compounds of N,N′-di(benzenesulfonyl)-p-phenylenediamine. Acta Crystallographica Section B Structural Science. 56(2). 234–244. 7 indexed citations
13.
Nagel, N., et al.. (1999). Diisopropylammonium diphenylmethylnitronate at 200K. Acta Crystallographica Section C Crystal Structure Communications. 55(7). 1147–1149. 1 indexed citations
15.
Nagel, N., Christian Näther, & Hans Bock. (1997). N,N'-Bis(4-methylbenzoyl)-p-phenylenediamine at 200K. Acta Crystallographica Section C Crystal Structure Communications. 53(1). 79–81. 4 indexed citations
16.
17.
Schramm, Hans J., Walter Göhring, E Jaeger, et al.. (1996). The inhibition of human immunodeficiency virus proteases by ‘interface peptides’. Antiviral Research. 30(2-3). 155–170. 73 indexed citations
18.
Vierl, Ulrich, et al.. (1994). Solute effects on the colloidal and phase behavior of lipid bilayer membranes: ethanol-dipalmitoylphosphatidylcholine mixtures. Biophysical Journal. 67(3). 1067–1079. 92 indexed citations
19.
Nagel, N., et al.. (1992). The mechanism of the solute-induced chain interdigitation in phosphatidylcholine vesicles and characterization of the isothermal phase transitions by means of dynamic light scattering. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1111(2). 263–269. 30 indexed citations
20.
Normand, B. Vulliez-Le, et al.. (1988). Structural identification of prostaglandin A1 biotransformation products from tumor cells. Prostaglandins. 35(4). 515–521. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026